LianBio
LIANY · OTC
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | — | -1.01M | -125.20M | -110.16M | -1.02 |
| 2023 FY | — | -1.33M | -99.54M | 311.14M | 2.88 |
| 2024 FY | — | -801.40K | -38.86M | 2.48M | 0.02 |
| 2025 FY | — | — | -1.27M | 4.91M | 0.05 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 319.96M | 26.31M | 79.22M | 4.34M | 259.87M |
| 2023 FY | 617.96M | 36.77M | 438.58M | 2.46M | 581.20M |
| 2024 FY | 63.72M | 859.00K | 51.70M | — | 62.87M |
| 2025 FY | 20.52M | 14.00K | 9.39M | — | 20.51M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | -99.07M | -1.84M | -100.91M | — | -148.96M |
| 2023 FY | 258.94M | -374.67K | 258.56M | — | 359.36M |
| 2024 FY | 3.75M | 2.00 | 3.75M | -550.70M | -386.88M |
| 2025 FY | 4.95M | 1.00 | 4.95M | -47.38M | -42.32M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 176.99M | 102.11M | — | — | — |
| 2023 FY | 482.40M | 46.28M | — | — | — |
| 2024 FY | 28.69M | -23.01M | — | — | — |
| 2025 FY | 10.37M | 980.95K | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2023 Q1 | — | -323.00K | -25.97M | -24.05M | -0.22 |
| 2023 Q2 | — | -297.00K | -25.04M | -21.62M | -0.20 |
| 2023 Q3 | — | -300.00K | -26.30M | -24.04M | -0.22 |
| 2023 Q4 | — | -347.00K | -22.47M | 383.73M | 3.56 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2023 Q1 | 302.58M | 28.16M | 102.33M | 3.92M | 240.65M |
| 2023 Q2 | 278.79M | 23.29M | 104.06M | 3.30M | 221.72M |
| 2023 Q3 | 262.90M | 26.79M | 103.46M | 2.84M | 202.34M |
| 2023 Q4 | 617.96M | 36.77M | 438.58M | 2.46M | 581.20M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2023 Q1 | -17.60M | -18.96K | -17.62M | — | 23.11M |
| 2023 Q2 | -19.13M | -49.62K | -19.18M | — | 1.72M |
| 2023 Q3 | -15.86M | -159.43K | -16.02M | — | -599.05K |
| 2023 Q4 | 311.52M | -146.66K | 311.38M | — | 335.13M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2023 Q1 | 210.04M | 111.62M | — | — | — |
| 2023 Q2 | 244.33M | 143.58M | — | — | — |
| 2023 Q3 | 159.68M | 59.07M | — | — | — |
| 2023 Q4 | 481.78M | 45.65M | — | — | — |